Assessing cognitive function in clinical trials of schizophrenia
- 1 July 2010
- journal article
- review article
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 34 (8) , 1161-1177
Abstract
No abstract availableKeywords
This publication has 157 references indexed in Scilit:
- Discrimination Learning, Reversal, and Set-Shifting in First-Episode Schizophrenia: Stability Over Six Years and Specific Associations with Medication Type and Disorganization SyndromeBiological Psychiatry, 2009
- Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophreniaPharmacology & Therapeutics, 2009
- IQ as a predictor of functional outcome in schizophrenia: A longitudinal, four-year study of first-episode psychosisSchizophrenia Research, 2009
- Set-Shifting Ability and Schizophrenia: A Marker of Clinical Illness or an Intermediate Phenotype?Biological Psychiatry, 2008
- Impaired conscious and preserved unconscious inhibitory processing in recent onset schizophreniaPsychological Medicine, 2008
- Symptoms versus neurocognition as predictors of change in life skills in schizophrenia after outpatient rehabilitationSchizophrenia Research, 2008
- Identifying Cognitive Mechanisms Targeted for Treatment Development in Schizophrenia: An Overview of the First Meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia InitiativeBiological Psychiatry, 2008
- Prediction of Psychosis in Youth at High Clinical RiskArchives of General Psychiatry, 2008
- Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trialNature Medicine, 2007
- d-Amphetamine remediates attentional performance in rats with dorsal prefrontal lesionsBehavioural Brain Research, 2004